1-6 of 6
Antonio Ledda, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Carfilzomib-Lenalidomide-Dexamethasone (KRd) Induction-Autologous Transplant (ASCT)-Krd Consolidation Vs KRd 12 Cycles Vs Carfilzomib-Cyclophosphamide-Dexamethasone (KCd) Induction-ASCT-KCd Consolidation: Analysis of the Randomized Forte Trial in Newly Diagnosed Multiple Myeloma (NDMM)

Francesca Gay, MD, Chiara Cerrato, MD, Delia Rota Scalabrini, MD, Monica Galli, MD, Angelo Belotti, MD, Elena Zamagni, MD, Antonio Ledda, MD, Mariella Grasso, MD, Emanuele Angelucci, MD, Anna Marina Liberati, MD, Patrizia Tosi, MD, Francesco Pisani, MD, Stefano Spada, Ombretta Annibali, MD, Anna Baraldi, MD, Paola Omedé, Piero Galieni, MD, Rita Rizzi, MD, Norbert Pescosta, MD, Sonia Ronconi, MD, Donatella Vincelli, MD, Anna Maria Cafro, MD, Massimo Offidani, MD, Antonio Palumbo, MD, Pellegrino Musto, MD, Michele Cavo, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 121.
https://doi.org/10.1182/blood-2018-99-112093
Published: 2018
Journal Articles

A Randomized Study of Carfilzomib-Lenalidomide-Dexamethasone Vs Carfilzomib-Cyclophosphamide-Dexamethasone Induction in Newly Diagnosed Myeloma Patients Eligible for Transplant: High Efficacy in High- and Standard-Risk Patients

Francesca Maria Gay, Delia Rota Scalabrini, MD, Angelo Belotti, MD, Monica Galli, MD PhD, Elena Zamagni, MD, Massimo Offidani, MD, Stefania Oliva, MD, Vittorio Montefusco, MD, Renato Zambello, MD, Antonio Ledda, MD, Mariella Grasso, MD, Sara Aquino, MD, Fabrizio Esma, Patrizia Tosi, MD, Francesco Pisani, MD, Ombretta Annibali, Anna Marina Liberati, Anna Baraldi, MD, Piero Galieni, MD, Giorgina Specchia, MD, Norbert Pescosta, MD, Katia Mancuso, MD, Laura Paris, MD, Rossella Ribolla, MD, Valentina Coha, MD, Antonio Palumbo, MD, Pellegrino Musto, MD, Michele Cavo, MD, Mario Boccadoro
Journal: Blood
Blood (2017) 130 (Supplement 1): 4541.
https://doi.org/10.1182/blood.V130.Suppl_1.4541.4541
Published: 2017
Journal Articles

Doublet Vs Triplet Lenalidomide-Containing Regimens in Newly Diagnosed Myeloma Patients, Younger or Older Than 75 Years: Subgroup Analysis of a Phase III Study

Valeria Magarotto, MD, Sara Bringhen, MD, Pellegrino Musto, MD, Massimo Offidani, MD, Anna Marina Liberati, MD, Ludek Pour, MD, Giulia Benevolo, MD, Mariella Genuardi, MD, Caterina Musolino, Antonio Ledda, MD, Daniela Oddolo, PhD, Lorenzo De Paoli, MD, Francesca Patriarca, MD, Antonietta Pia Falcone, MD, Isola Caratozzolo, Renato Zambello, MD, Maide Cavalli, MD, Silvia Gentili, MD, Roman Hajek, Mario Boccadoro, MD, Antonio Palumbo, MD
Journal: Blood
Blood (2014) 124 (21): 2110.
https://doi.org/10.1182/blood.V124.21.2110.2110
Published: 2014
Journal Articles

A Randomized Phase 3 Trial Of Melphalan-Lenalidomide-Prednisone (MPR) Or Cyclophosphamide-Prednisone-Lenalidomide (CPR) Vs Lenalidomide Plus Dexamethsone (Rd) In Elderly Newly Diagnosed Multiple Myeloma Patients

Antonio Palumbo, MD, Valeria Magarotto, Sara Bringhen, MD, Massimo Offidani, MD, Giuseppe Pietrantuono, MD, Anna Marina Liberati, MD, Giulia Benevolo, MD, Antonio Ledda, MD, Milena Gilestro, Monica Galli, MD, Francesca Patriarca, MD, Mariella Genuardi, MD, Nicola Giuliani, MD, Renato Zambello, MD, Adam Zdenek, Alessia La Fauci, MD, Paolo Corradini, Antonietta Pia Falcone, MD, Caterina Musolino, MD, Davide Rossi, MD, Ph.D., Patrizia Caraffa, MD, Pellegrino Musto, MD, Federica Cavallo, MD, Roman Hajek, MD, PhD, Mario Boccadoro, MD
Journal: Blood
Blood (2013) 122 (21): 536.
https://doi.org/10.1182/blood.V122.21.536.536
Published: 2013
Journal Articles

Bortezomib-Thalidomide-Dexamethasone Incorporated Into Autotransplantation Is Associated with More Favorable Outcomes After Relapse in Comparison with Thalidomide-Dexamethasone Plus Autotransplantation in Multiple Myeloma

Michele Cavo, MD, Monica Galli, MD, Lucia Pantani, MD, Francesco Di Raimondo, MD, Claudia Crippa, MD, Massimo Offidani, MD, Elena Zamagni, MD, Vittorio Montefusco, MD, Franco Narni, MD, Annalisa Pezzi, Antonio Spadano, MD, Norbert Pescosta, MD, Paola Tacchetti, MD, Luca Baldini, MD, Antonio Ledda, MD, Claudia Cellini, MD, Tommaso Caravita, MD, Antonietta Falcone, MD, Chiara Nozzoli, MD, Renato Zambello, MD, Luciano Masini, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2012) 120 (21): 4210.
https://doi.org/10.1182/blood.V120.21.4210.4210
Published: 2012
Journal Articles

Superior Complete Response Rate (CR) and Progression-Free Survival (PFS) with Bortezomib-Thalidomide-Dexamethasone (VTD) Versus Thalidomide-Dexamethasone (TD) As Consolidation Therapy After Autologous Stem-Cell Transplantation (ASCT) in Multiple Myeloma (MM)

Michele Cavo, MD, Lucia Pantani, MD, Francesca Patriarca, MD, Maria Teresa Petrucci, Monica Galli, MD, Francesco Di Raimondo, MD, Giuseppe Rossi, MD, Antonio Palumbo, MD, Paola Tacchetti, MD, Massimo Offidani, MD, Vittorio Montefusco, MD, Franco Narni, MD, Tonino Spadano, MD, Claudia Cellini, MD, Norbert Pescosta, MD, Luca Baldini, MD, Antonio Ledda, MD, Tommaso Caravita Di Toritto, MD, Annalisa Pezzi, Statistician, Antonietta Falcone, MD, Chiara Nozzoli, MD, Renato Zambello, MD, Luciano Masini, MD, Filippo Gherlinzoni, MD, Maria Concetta Petti, MD, Daniele Derudas, MD, Stelvio Ballanti, MD, Valerio De Stefano, MD, Michele Baccarani, MD
Journal: Blood
Blood (2011) 118 (21): 1871.
https://doi.org/10.1182/blood.V118.21.1871.1871
Published: 2011